Skip Navigation LinksHome > June 1, 2013 - Volume 63 - Issue 2 > Nevirapine Inhibits the Anti-HIV Activity of CD8+ Cells
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e318289822d
Brief Report: Basic and Translational Science

Nevirapine Inhibits the Anti-HIV Activity of CD8+ Cells

Liu, Lianxing PhD*,†; Wang, Lin MS*,†; Huang, Liusheng PhD; Siu, Vincent BS*,†; Teque, Fernando BS*,†; Aweeka, Francesca T. PharmD; Levy, Jay A. MD

Supplemental Author Material
Collapse Box


Abstract: Antiretroviral therapy (ART) significantly reduced the CD8+ cell noncytotoxic anti-HIV response in 12 HIV-1–infected subjects (P < 0.0001). In separate experiments, CD8+ cells from long-term survivors were cocultured with HIV-infected CD4+ cells using varying concentrations of anti-HIV drugs. The antiviral function of CD8+ cells from 4 of the 14 LTSs was reduced with exposure to 10 μM of nevirapine (P < 0.05). The antiviral activity of CD8+ cells from 2 LTSs was inhibited by 5 μM of zidovudine. These studies indicate that nevirapine and probably zidovudine can inhibit the anti-HIV activity of CD8+ cells and thus could influence the effectiveness of antiretroviral therapy.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.